e-learning
resources
Monograph
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The global perspective of occupational lung disease
Mohamed F. Jeebhay
Source:
Eur Respir Monogr 2020; 89: 1-18
Journal Issue:
Occupational and Environmental Lung Disease
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mohamed F. Jeebhay. The global perspective of occupational lung disease. Eur Respir Monogr 2020; 89: 1-18
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Expert interview: Microbiologists on tuberculosis diagnostics
Related content which might interest you:
Work, workplace and fitness considerations in patients with occupational lung diseases
Source: Virtual Congress 2020 – How much lung disease is really caused by work, and how to assess the worker who wishes to continue working?
Year: 2020
Smoking-related lung diseases: a clinical perspective
Source: Eur Respir J 2010; 35: 231-233
Year: 2010
Current and new challenges in occupational lung diseases
Source: Eur Respir Rev, 26 (146) 170080; 10.1183/16000617.0080-2017
Year: 2017
The natural history of untreated NTM lung disease: a global perspective
Source: International Congress 2017 – Clinical impact of nontuberculous mycobacterial (NTM) disease
Year: 2017
Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes
Source: Eur Respir J, 55 (1) 1900647; 10.1183/13993003.00647-2019
Year: 2020
The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective
Source: International Congress 2019 – Rare lung diseases
Year: 2019
Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention
Source: Eur Respir J 2006; 28: 397-408
Year: 2006
Using digital and social media to highlight the risks of occupational exposures as a cause of lung diseases
Source: Virtual Congress 2020 – Workplace and outdoor air quality: from sensitisation to social media
Year: 2020
Using digital and social media to highlight the risks of occupational exposures as a cause of lung diseases
Source: International Congress 2018 – Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches
Year: 2018
The global burden of pulmonary disease: where we are and where we are going
Source: International Congress 2019 – The future of respiratory diseases: what prevention can do
Year: 2019
Reduction of work exposure is not associated with improvement in functional and biological findings in occupational asthma
Source: Annual Congress 2006 - Asthma at the workplace – the prognosis and the costs
Year: 2006
Lung cancer: the global burden of the disease
Source: International Congress 2015 – Lung cancer screening: how to implement a comprehensive preventive approach
Year: 2015
Controversies in epidemiology of occupational asthma
Source: Eur Respir J 2003; 22: 551-559
Year: 2003
α1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants
Source: Eur Respir J 2005; 26: 909-917
Year: 2005
An international survey on genetics in clinical practice for interstitial lung disease.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Occupational exposures and COPD: an ecological analysis of international data
Source: Eur Respir J 2009; 33: 298-304
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept